Cobenfy doesn’t have the same severe side effects as older schizophrenia medications — like weight gain, involuntary muscle ...

Symptoms of gastroparesis, such as chronic nausea, vomiting, early satiety, postprandial fullness, abdominal pain, bloating, ...

With Thursday approval from the U.S. Food and Drug Administration for Cobenfy, adults living with schizophrenia will have ...

“It’s vital for women to trust their instincts regarding their health. If something feels off or unusual, they should not ...

Functional dyspepsia is a common digestive disorder, with more than one in ten Koreans suffering. Some of these patients wander from one hospital to another, searching for a precise cause and ...

Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...

Formally known as KarXT, xanomeline-trospium chloride (Cobenfy) receives approval from the FDA for the treatment of ...

On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel ...

DGL supplements contain licorice and are an alternative to drugstore acid reflux options. Learn how DGL without glycyrrhizin ...

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...

On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of ...